Following is the list for NSP's past 12 month announcements:I...

Following is the list for NSP's past 12 month announcements:

I thumb up for the achievements NSP made during this period.
well done NSP board!

745308 17/07/13 15:25 Initial Substantial Shareholder 161 N View 6
744323 10/07/13 14:38 Research Report on NuSep 55 N View 10
744316 10/07/13 14:05 NuSep Investor Presentation 1063 N View 12
744143 09/07/13 12:13 NuSep Announces Long Term Debt Management 56 Y View 11
743786 05/07/13 11:36 Change of Address & Registered Office 31 N View 4

741383 24/06/13 11:22 NuSep - New Headquarters 347 N View 7
739441 11/06/13 11:35 PrIME Receives Plasma Importation License 52 Y View 8
738411 03/06/13 11:13 NuSep Signs LOI to Fund PrIME 56 Y View 16
738409 03/06/13 10:39 Company Secretary Update 55 N View 8
737928 30/05/13 10:40 First PrIME Franchise Proposal 56 Y View 12
736789 23/05/13 10:55 Dengue Diagnostic & Therapeutic - New Application of PrIME 72 Y View 10
736351 21/05/13 11:13 NuSep Appoints KPMG as Company Auditor 55 N View 5
736148 20/05/13 11:52 NuSep Update 133 Y View 11
735437 15/05/13 10:02 PrIME Update 1410 Y View 14
734449 08/05/13 17:25 NSP Cleansing Notice 136 N View 6
733279 01/05/13 13:33 Resignation of Auditor 2295 N View 9
733227 01/05/13 10:31 NuSep Singapore PrIME Fundraising and Appendix 3B 1551 Y View 15
726233 15/03/13 14:27 Divestiture of non-core ProteoIQ software 1375 N View 10
723932 01/03/13 17:42 Reinstatement to Official Quotation 25 Y View 4
723870 01/03/13 17:42 NuSep Half Year Report & Accounts 790 Y View 22
723780 01/03/13 10:28 AEJ: Suspension from Official Quotation 15 Y View 6
720683 15/02/13 16:18 Appointment of New Company Secretary 125 N View 7
717385 25/01/13 12:04 Updated NuSep Charters 205 N View 6
717277 24/01/13 17:50 Ceasing to be a substantial holder 1355 N View 9
717276 24/01/13 17:49 Becoming a substantial holder 2922 N View 8
717176 24/01/13 10:38 NuSep divests non Core ProteoIQ software 56 Y View 6
715652 10/01/13 12:23 PrIME Completes lease for Singapore cGMP Facility 44 N View 8
715489 09/01/13 09:28 Substantial Shareholder Notice 123 N View 6
715453 08/01/13 18:07 Change in substantial holding 659 N View 6
715359 08/01/13 10:50 PrIME completes first three trial production runs of Albumin 45 Y View 4
714727 02/01/13 14:26 NuSep receives Final Tranche payment and Appendix 3B 157 N View 7
712711 17/12/12 16:39 NuSep Receives $1.54m R&D Tax Refund 40 N View 7
712064 13/12/12 09:51 Response to ASX Letter re Disclaimer of Audit Opinion 88 N View 4
711586 11/12/12 09:38 Change of Director's Interest Notice 15 N View 6
711582 11/12/12 09:36 Amendment of 2012 AGM Poll numbers 42 N View 1
711011 06/12/12 16:26 Change of Director's Interest Notice - Manusu, Nair, Goodall 37 N View 7
711010 06/12/12 16:26 Appendix 3B 158 N View 4
710461 04/12/12 14:14 Final Director's Interest Notices 469 N View 1
710452 04/12/12 14:09 Update on PrIME Spin Out Resolution 44 Y View 10
710454 04/12/12 13:57 Initial Director's Interest Notice - P Patel and C Eu 15 N View 4
709874 30/11/12 14:21 Results of Meeting 54 N View 4
709828 30/11/12 12:28 Board Update 149 Y View 4
709827 30/11/12 12:22 Shareholder Update 2331 N View 10
709249 28/11/12 14:59 Board Changes 37 N View 13
708043 22/11/12 15:30 Appendix 3B 175 N View 7
706616 15/11/12 10:52 Prof John Aitken Awarded as NSW Scientist of the Year 2012 41 N View 4
705890 12/11/12 12:26 NuSep achieves TGA accreditation for Diagnostics 42 Y View 5
704403 02/11/12 08:29 Becoming a substantial holder 125 N View 9
704402 02/11/12 08:29 Cleansing Notice 35 N View 6
703878 31/10/12 14:37 NuSep Annual Report 2012 1845 N View 6
703566 30/10/12 18:05 NuSep NOM 2012 AGM and EGM 173 N View 7
703437 30/10/12 13:57 Appendix 3B 135 N View 7
703417 30/10/12 13:01 NuSep Makes a 15% Placement 42 Y View 14
703390 30/10/12 12:18 NuSep Updated Board Charters 170 N View 5
703383 30/10/12 11:41 Correction to Spin Out of PrIME Biologics And Update of Time 43 N View 4
702851 29/10/12 15:10 NuSep clears shares held in suspense account 40 N View 2
700185 15/10/12 15:35 NuSep 2012 AGM 40 N View 7
700098 15/10/12 10:36 Spin Out of PrIME Biologics 59 Y View 5
698197 03/10/12 14:26 Critical Milestone with Installation of PrIME unit in Singap 149 Y View 7
697995 02/10/12 16:33 Substantial Shareholder Notice 237 N View 8
697633 28/09/12 19:03 Annual Financial Report 30 June 2012 926 N View 10
697112 27/09/12 15:22 NuSep Working Capital Advance and update on DCS Debt 42 Y View 3
693401 06/09/12 11:07 Research Report on NuSep 39 N View 16
692202 30/08/12 10:27 NuSep announces 30 June 2012 Full Year Results 87 Y View 8
691729 28/08/12 11:26 Update on PrIME Developments and impact on 30.06.12 results 44 Y View 11
690652 21/08/12 13:27 Notice to holders of 35 cent options (NSPO) 888 N View 6
690072 16/08/12 14:08 NuSep Restructures Board and Company to Focus on PrIME techn 66 Y View 13
689661 14/08/12 10:49 NSP receives S$6M investment in Singapore Plasma Businesss 287 Y View 18
687551 27/07/12 16:00 Change of Director's Interest Notice 15 N - 2
687057 24/07/12 14:15 Change in substantial holding 188 N View 16
686761 20/07/12 15:55 Appendix 3B 70 N View 13
683624 25/06/12 16:29 Change in substantial holding 949 N View 8
683605 25/06/12 15:46 Change of Director's Interest Notice 57 N View 3
683362 22/06/12 12:25 Results of Meeting 154 N View 2
683361 22/06/12 12:22 NuSep General Meeting presentation 2012 1059 N View 8
682266 14/06/12 10:29 NuSep Settles NxGen Legal Case 39 Y View 11
681465 06/06/12 11:21 NuSep Investor Presentation 854 N View 12
681318 05/06/12 10:54 NuSep Expands Gels Distribution with BioExpress in the US 43 Y View 4
680402 29/05/12 10:26 NuSep Lodges Two Patent Applications 39 Y View 6
680084 25/05/12 11:46 Change of Company Secretary 34 N View 5
679648 22/05/12 15:58 Notice of General Meeting/Proxy Form 1171 N View 8
679265 18/05/12 10:48 NuSep raises $200,000 42 N View 12
678883 16/05/12 09:52 Letter from the Chairman 159 N View 14
678630 14/05/12 15:07 Proposal to change auditor of the Company 35 N View 8
676198 26/04/12 12:02 HOA to establish Singapore Plasma Fractionation Facility 815 Y View 12
675403 18/04/12 17:16 Appendix 3B 44 N View 3
673981 04/04/12 12:04 Appendix 3B 44 N View 1
673546 02/04/12 10:09 Update on Payment of $1.8M on Exercise of Share Options 715 Y View 12
673330 30/03/12 11:28 NuSep Working Capital Advance 152 Y View 9
672499 23/03/12 15:48 Notice to holders of 15 cent options (NSPOA) 234 N View 7
671998 20/03/12 13:52 Final Director's Interest Notice 55 N View 3
671859 19/03/12 15:36 NuSep Board Changes 152 N View 6
671681 16/03/12 16:00 Initial Director's Interest Notice 731 N View 7
671301 14/03/12 15:50 Andrew Goodall Joins NuSep Board 152 N View 10
670928 12/03/12 13:42 Response to ASX Letter re Disclaimer of Audit Opinion 122 N View 7
670240 06/03/12 12:26 NuSep signs Distribution Agreement with In Vitro Technologie 158 Y View 7
669489 01/03/12 10:07 Correction to Appendix 4D 77 Y View 5
669433 29/02/12 20:13 NuSep announces Half Year Profit 221 Y View 6
667616 20/02/12 16:22 Director Resignation and Appendix 3Z 773 N View 4
661358 16/12/11 14:18 Professor John Aitken receives award for SpermSep technology 626 N View 5